RNA editing is rapidly gaining prominence as its transient and reversible changes promise a safer and more flexible option to reverse disease-causing mutations than DNA editing.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Programmable editing of primary MicroRNA switches stem cell differentiation and improves tissue regeneration
Nature Communications Open Access 27 September 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
16 March 2023
In the version of this article initially published, in the sentence now reading "'We’re seeing durable, consequential editing,' says Paul Bolno, CEO at Wave," there originally appeared an additional mention of editing in non-human primates, which is now removed from the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Shoot the messenger: RNA editing is here. Nat Biotechnol 41, 306–308 (2023). https://doi.org/10.1038/s41587-023-01709-8
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41587-023-01709-8
This article is cited by
-
Programmable editing of primary MicroRNA switches stem cell differentiation and improves tissue regeneration
Nature Communications (2024)
